ID
41473
Descripción
Study ID: 105043/013 Clinical Study ID: 105043/013 Study Title: An Open-Label Study of Argatroban Injection to Evaluate the Safety and Effectiveness in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin (Protocol SKF105043/013) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00039858 - See https://clinicaltrials.gov/ct2/show/NCT00039858 Sponsor: GlaxoSmithKline Collaborators: Encysive Pharmaceuticals Phase: Phase 4 Study Recruitment Status: Completed Generic Name: Argatroban Trade Name: N/A Study Indication: Thrombosis This Study evaluates the safety and the efficacy of i.v. Argatroban treatment in paediatric patients which require anticoagulants but aren't suitable for Heparin treatment. The study consists of screening visit (pre-treatment examination), treatment period of maximum 14 days after reaching therapeutical dose, post-treatment visit (once the treatment is stopped or after 14 days) and a follow-up visit which follows 30 days (+/- 14 days) after clinical resolution of underlying condition or after the end of the 14-day study period. Treatment can be continued after the 14-day study period if needed but such treatment isn't part of this Study. The Concomitant Medications (Non-Continuous Infusion) Form has to be filled in each time any change in medication (except for those administered as a continuous infusion) occurs during the Study. Please use one Instance of this Form per medication administered.
Link
https://clinicaltrials.gov/ct2/show/NCT00039858
Palabras clave
Versiones (1)
- 21/10/20 21/10/20 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
21 de octubre de 2020
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Safety and Efficacy of Argatroban in Pediatric Patients, NCT00039858
Concomitant Medications (Non-Continuous Infusion)
- StudyEvent: ODM
Descripción
Check if No Concomitant Medications were given:
Alias
- UMLS CUI-1
- C2347852
- UMLS CUI-2
- C1705847
- UMLS CUI-3
- C1511497
- UMLS CUI-4
- C0549184
Descripción
(except for continuous IV infusions) Otherwise, please complete below and do not record more than ONE medication on same instance. Include all medications taken within 14 days, and all investigational drugs taken within 30 days (if investigational drug is administered within 30 days, please contact Medical Monitor [protocol violation]), prior to initiation of Argatroban infusion, and throughout study and 30-day follow-up period.
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C1705847
- UMLS CUI [1,3]
- C1511497
- UMLS CUI [1,4]
- C0549184
Descripción
Concomintant Medications (Non-Continuous Infusion)
Alias
- UMLS CUI-1
- C2347852
- UMLS CUI-2
- C1705847
- UMLS CUI-3
- C1511497
Descripción
Use a new instance if more than 6 lines are required. Also do not record more than ONE medication on the same instance.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C2348184
Descripción
(Prefer Trade Name)
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2360065
- UMLS CUI [1,2]
- C2347852
Descripción
Concomitant agent dose and dose unit
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C3174092
- UMLS CUI [2]
- C2826646
Descripción
Concomitant agent route of admission
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0013153
Descripción
Concomitant agent route of admission - specify
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0013153
- UMLS CUI [1,3]
- C1521902
Descripción
Concomitant agent dosing frequency
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826654
Descripción
(dd-mmm-yyyy)
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0808070
Descripción
(0000-2359)
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C1301880
Descripción
(dd-mmm-yyyy)
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0806020
Descripción
(0000-2359)
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C1522314
Descripción
Concomitant agent ongoing
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C2826666
Descripción
Concomitant agent indication
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C3146298
Similar models
Concomitant Medications (Non-Continuous Infusion)
- StudyEvent: ODM
C0019994 (UMLS CUI [1,2])
C2348184 (UMLS CUI [1,2])
C1705847 (UMLS CUI-2)
C1511497 (UMLS CUI-3)
C0549184 (UMLS CUI-4)
C1705847 (UMLS CUI [1,2])
C1511497 (UMLS CUI [1,3])
C0549184 (UMLS CUI [1,4])
C1705847 (UMLS CUI-2)
C1511497 (UMLS CUI-3)
C2347852 (UMLS CUI [1,2])
C3174092 (UMLS CUI [1,2])
C2826646 (UMLS CUI [2])
C0013153 (UMLS CUI [1,2])
C0013153 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,3])
C0808070 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C1522314 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,2])